The U.S. Food and Drug Administration has granted AliveCor the designation of ‘breakthrough device’ for it’s ability to detect a rare but dangerous blood condition called hyperkalemia without taking any blood from the patient. Hyperkalemia is a medical term describing elevated potassium levels in the blood and is usually found in those with kidney disease. […]...